Despite the accumulating knowledge, chronic hepatitis B (CHB) and HDV infection represent a global health problem, and there are still several critical issues, which frequently remain uncovered. In this paper, we provided an overview of the current therapeutic options and summarized the investigational therapies in the pipeline. Furthermore, we discussed some critical issues such as a "functional cure" approach, the futility of long-term NA therapy and the relevance of understanding drug actions and safety of antivirals, especially in special populations.
HBV and HDV: New Treatments on the Horizon / V. Zuccaro, E. Asperges, M. Colaneri, L.N. Marvulli, R. Bruno. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 10:18(2021 Sep 08), pp. 4054.1-4054.13. [10.3390/jcm10184054]
HBV and HDV: New Treatments on the Horizon
V. Zuccaro
Primo
;M. Colaneri;
2021
Abstract
Despite the accumulating knowledge, chronic hepatitis B (CHB) and HDV infection represent a global health problem, and there are still several critical issues, which frequently remain uncovered. In this paper, we provided an overview of the current therapeutic options and summarized the investigational therapies in the pipeline. Furthermore, we discussed some critical issues such as a "functional cure" approach, the futility of long-term NA therapy and the relevance of understanding drug actions and safety of antivirals, especially in special populations.
| File | Dimensione | Formato | |
|---|---|---|---|
|
HBV and HDV- New Treatments on the Horizon .pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
289.95 kB
Formato
Adobe PDF
|
289.95 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
